← The Wire
MGTXNasdaq
MeiraGTx Holdings plc
Biological Products, (No Diagnostic Substances) · CIK 1735438
Develops and manufactures genetic medicines for inherited and common conditions using proprietary platforms and in-house GMP manufacturing
$888M
Market cap
$12.54
Last close
+3.5%
1D
+9.2%
5D
683K
Volume
Price · last 39 sessions+29.3%
May 4L $9.00 · H $12.54Jun 29
150
Total filings
Jun 15, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 15, 202610-Q10-QMay 14, 20268-KResults of OperationsMay 14, 2026DEFA14ADEFA14AApr 30, 2026DEF 14ADEF 14AApr 30, 20268-KMaterial AgreementApr 24, 2026SC 13D/ASC 13D/AApr 24, 2026424B5424B5Apr 16, 20268-KMaterial AgreementApr 16, 20268-KMaterial Agreement · Agreement TerminatedApr 16, 20268-KReg FD Disclosure · Company UpdateApr 16, 202610-K10-KMar 30, 20268-KMaterial Agreement · Results of OperationsMar 26, 20268-KMaterial AgreementJan 2, 2026SC 13D/ASC 13D/AJan 2, 202610-Q10-QNov 13, 20258-KResults of OperationsNov 13, 20258-KMaterial Agreement · Reg FD DisclosureNov 10, 202510-Q10-QAug 14, 20258-KResults of OperationsAug 14, 20258-KReg FD DisclosureJun 26, 20258-KShareholder VoteJun 17, 202510-Q10-QMay 13, 20258-KResults of OperationsMay 13, 20258-KReg FD DisclosureMay 9, 2025DEFA14ADEFA14AApr 30, 2025DEF 14ADEF 14AApr 30, 20258-KMaterial Agreement · Agreement TerminatedApr 4, 202510-K10-KMar 13, 20258-KMaterial Agreement · Results of OperationsMar 13, 20258-KCompany UpdateDec 9, 202410-Q10-QNov 13, 20248-KResults of OperationsNov 13, 20248-KReg FD Disclosure · Company UpdateOct 15, 20248-KCompany UpdateAug 13, 2024424B5424B5Aug 12, 20248-KResults of OperationsAug 12, 202410-Q10-QAug 12, 20248-KShareholder VoteJun 10, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 20248-K/AExecutive ChangeApr 16, 202410-K10-KMar 15, 20248-KResults of OperationsMar 14, 20248-KCompany UpdateFeb 13, 20248-KMaterial Agreement · Agreement TerminatedDec 21, 202310-Q10-QNov 14, 20238-KResults of OperationsNov 14, 20238-KMaterial Agreement · Equity IssuanceOct 30, 202310-Q10-QAug 10, 20238-KMaterial Agreement · Results of OperationsAug 10, 20238-KShareholder VoteJun 12, 2023SC 13GSC 13GMay 15, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 20238-KMaterial Agreement · Equity IssuanceMay 9, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 27, 20238-KExecutive ChangeApr 26, 202310-K10-KMar 14, 20238-KResults of OperationsMar 14, 20238-KReg FD DisclosureMar 10, 2023DEFA14ADEFA14AJan 20, 2023DEF 14ADEF 14ADec 23, 202210-Q10-QNov 10, 20228-KMaterial Agreement · Results of OperationsNov 10, 202210-Q10-QAug 11, 20228-KResults of OperationsAug 11, 20228-KMaterial Agreement · New Debt / ObligationAug 4, 20228-KExecutive ChangeJun 27, 20228-KShareholder VoteJun 9, 202210-Q10-QMay 12, 20228-KResults of OperationsMay 12, 2022DEF 14ADEF 14AMay 2, 20228-KExecutive Change · Reg FD DisclosureApr 27, 202210-K10-KMar 10, 20228-KResults of OperationsMar 10, 20228-KReg FD DisclosureDec 7, 2021
Insider Activity
In the 90 days to Mar 24, 2026: 1 sold $459K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 24, 2026 | Forbes AlexandriaPRESIDENT & CEO | Sell | 62,000 | $7.41 | $459K |
| Oct 21, 2025 | Giroux RichardCFO & COO | Sell | 24,000 | $8.87 | $213K |
| Oct 7, 2025 | Forbes AlexandriaPRESIDENT & CEO | Sell | 47,500 | $8.39 | $399K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance